Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Frontiers in Oncology|October 11, 2021
Harnessing DNA Repair Defects to Augment Immune-Based Therapies in Triple-Negative Breast CancerCurtis A Clark, Eddy S Yang
Journal of Immunotherapy and Precision Oncology|February 8, 2023
Therapeutic Targeting of DNA Damage Repair in the Era of Precision Oncology and Immune Checkpoint InhibitorsCurtis A Clark, Eddy S Yang
American Journal of Respiratory Cell and Molecular Biology|July 16, 2011
Inhibition of protein kinase C attenuates Pseudomonas aeruginosa elastase-induced epithelial barrier disruptionCurtis A Clark, Lauren K Thomas, Ali O Azghani
Autophagy|April 4, 2017
Tumor cell-intrinsic CD274/PD-L1: A novel metabolic balancing act with clinical potentialCurtis A Clark, Harshita B Gupta, Tyler J Curiel
Frontiers in Immunology|December 27, 2021
Durable Metastatic Melanoma Remission Following Pembrolizumab and Radiotherapy: A Case Report of Prophylactic Immunosuppression in a Patient with Myasthenia Gravis and Immune-Mediated ColitisLuke A Moradi, Curtis A Clark, Craig S Schneider, et al.
Thrombosis and Haemostasis|February 29, 2012
Factor VIIa binding to endothelial cell protein C receptor: differences between mouse and human systemsProsenjit Sen, Curtis A Clark, Ramakrishnan Gopalakrishnan, et al.
Blood|January 22, 2011
Factor VIIa bound to endothelial cell protein C receptor activates protease activated receptor-1 and mediates cell signaling and barrier protectionProsenjit Sen, Ramakrishnan Gopalakrishnan, Hema Kothari, et al.
Oncoimmunology|December 3, 2021
CD122-targeted interleukin-2 and αPD-L1 treat bladder cancer and melanoma via distinct mechanisms, including CD122-driven natural killer cell maturationRyan M Reyes, Chenghao Zhang, Yilun Deng, et al.
Journal for Immunotherapy of Cancer|January 19, 2021
Estrogen receptor beta signaling in CD8+ T cells boosts T cell receptor activation and antitumor immunity through a phosphotyrosine switchBin Yuan, Curtis A Clark, Bogang Wu, et al.
Signal Transduction and Targeted Therapy|August 12, 2017
Tumor cell-intrinsic PD-L1 promotes tumor-initiating cell generation and functions in melanoma and ovarian cancerHarshita B Gupta, Curtis A Clark, Bin Yuan, et al.
Pageof 2